Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuanjiao Fang 1 is a traditional Chinese medicine (TCM) herbal formula currently under clinical investigation for the treatment of allergic conjunctivitis. The specific composition of Chuanjiao Fang 1 is not detailed in the available sources, but its name suggests it contains "chuan jiao" (Szechuan pepper, Zanthoxylum bungeanum), a commonly used herb in TCM known for its properties to warm the middle jiao (digestive system), alleviate pain, stop diarrhea, and kill parasites[1][4][5]. Chuan Jiao is traditionally used for conditions such as cold from deficiency in the stomach and spleen, abdominal pain, diarrhea, toothache, and parasitic infections. The mechanism of action likely involves modulation of gastrointestinal function and anti-parasitic effects; however, for allergic conjunctivitis specifically, the mechanism remains unclear. Clinical trials are ongoing to evaluate its efficacy and safety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chuanjiao fang 1.